BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16081918)

  • 1. Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase.
    Pagani L; Colinon C; Migliavacca R; Labonia M; Docquier JD; Nucleo E; Spalla M; Li Bergoli M; Rossolini GM
    J Clin Microbiol; 2005 Aug; 43(8):3824-8. PubMed ID: 16081918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
    Cezário RC; Duarte De Morais L; Ferreira JC; Costa-Pinto RM; da Costa Darini AL; Gontijo-Filho PP
    Enferm Infecc Microbiol Clin; 2009 May; 27(5):269-74. PubMed ID: 19386392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program.
    Mendes RE; Toleman MA; Ribeiro J; Sader HS; Jones RN; Walsh TR
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4693-702. PubMed ID: 15561846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia.
    Lim KT; Yasin RM; Yeo CC; Puthucheary SD; Balan G; Maning N; Wahab ZA; Ismail N; Tan EA; Mustaffa A; Thong KL
    J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-beta-lactamase in a Korean hospital.
    Ryoo NH; Lee K; Lim JB; Lee YH; Bae IK; Jeong SH
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):115-7. PubMed ID: 18993011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.
    Cagnacci S; Gualco L; Roveta S; Mannelli S; Borgianni L; Docquier JD; Dodi F; Centanaro M; Debbia E; Marchese A; Rossolini GM
    J Antimicrob Chemother; 2008 Feb; 61(2):296-300. PubMed ID: 18065411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.
    Cornaglia G; Mazzariol A; Lauretti L; Rossolini GM; Fontana R
    Clin Infect Dis; 2000 Nov; 31(5):1119-25. PubMed ID: 11073738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006.
    Patzer JA; Walsh TR; Weeks J; Dzierzanowska D; Toleman MA
    J Antimicrob Chemother; 2009 Feb; 63(2):269-73. PubMed ID: 19095681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China.
    Dong F; Xu XW; Song WQ; Lü P; Yu SJ; Yang YH; Shen XZ
    Chin Med J (Engl); 2008 Sep; 121(17):1611-6. PubMed ID: 19024085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy.
    Pagani L; Mantengoli E; Migliavacca R; Nucleo E; Pollini S; Spalla M; Daturi R; Romero E; Rossolini GM
    J Clin Microbiol; 2004 Jun; 42(6):2523-9. PubMed ID: 15184430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity.
    Lagatolla C; Edalucci E; Dolzani L; Riccio ML; De Luca F; Medessi E; Rossolini GM; Tonin EA
    J Clin Microbiol; 2006 Jul; 44(7):2348-53. PubMed ID: 16825348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans.
    Yamamoto M; Nagao M; Hotta G; Matsumura Y; Matsushima A; Ito Y; Takakura S; Ichiyama S
    J Antimicrob Chemother; 2012 Sep; 67(9):2110-3. PubMed ID: 22577105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location.
    Pellegrini C; Mercuri PS; Celenza G; Galleni M; Segatore B; Sacchetti E; Volpe R; Amicosante G; Perilli M
    J Antimicrob Chemother; 2009 May; 63(5):901-8. PubMed ID: 19270313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia.
    Libisch B; Poirel L; Lepsanovic Z; Mirovic V; Balogh B; Pászti J; Hunyadi Z; Dobák A; Füzi M; Nordmann P
    FEMS Immunol Med Microbiol; 2008 Dec; 54(3):330-8. PubMed ID: 19049645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
    Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial outbreak of OXA-18-producing Pseudomonas aeruginosa in Tunisia.
    Kalai Blagui S; Achour W; Abbassi MS; Bejaoui M; Abdeladhim A; Ben Hassen A
    Clin Microbiol Infect; 2007 Aug; 13(8):794-800. PubMed ID: 17610599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.